Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 37
Filter
Add more filters










Publication year range
1.
J Appl Glycosci (1999) ; 63(3): 69-75, 2016.
Article in English | MEDLINE | ID: mdl-34354485

ABSTRACT

A spherical gel containing amino groups was prepared using monomers of N,N-dimethylacrylamide and N,N-dimethylaminoethyl methacrylate, with a cross-linker composed of N,N'-methylenebisacrylamide prepared by suspension polymerization for the adsorption of glucuronic acid and chondroitin sulfate. The prepared gel was immersed in glucose, glucuronic acid, and chondroitin sulfate solutions to determine the adsorption performance in batch mode, which demonstrated that 20 % of the chondroitin sulfate was adsorbed to the amino-group-containing gel. The amino-group-containing gel was packed into a column to permeate the chondroitin sulfate-containing solution (0.40 g/L) at pH 2.0, and it adsorbed chondroitin sulfate to the gel at a space velocity of 4.5 h-1. When the space velocity was changed to 1.5 h-1, the amount of chondroitin sulfate increased. When 0.50 M NaCl solution was permeated through the chondroitin-sulfate-adsorbed gel in column mode, 70 % of the chondroitin sulfate was eluted. This spherical gel may be applicable for acidic glycan recovery using batch and permeation modes.

2.
Enzyme Res ; 2011: 896567, 2011.
Article in English | MEDLINE | ID: mdl-21755044

ABSTRACT

Recent observations on environment-linked control of genetically prescribed signaling systems for either cell activation or cell death have been reviewed with a focus on the regulation of activities of protein tyrosine kinases (PTKs). The environment-linked redox reactions seem to primarily affect cell surface receptors and cell membrane lipid rafts, and they induce generation of reactive oxygen species (ROS) in cells. ROS thus generated might upregulate the catalytic activities of PTKs through inactivating protein tyrosine phosphatases that dephosphorylate and inactivate autophosphorylated PTKs. Recent evidence has, however, demonstrated that ROS could also directly oxidize SH groups of genetically conserved specific cysteines on PTKs, sometimes producing disulfide-bonded dimers of PTK proteins, either for upregulation or downregulation of their catalytic activities. The basic role of the redox reaction/covalent bond-mediated modification of protein tertiary structure-linked noncovalent bond-oriented signaling systems in living organisms is discussed.

3.
J Cell Biochem ; 108(5): 1059-65, 2009 Dec 01.
Article in English | MEDLINE | ID: mdl-19830705

ABSTRACT

Although methane sulfonate compounds are widely used for the protein modification for their selectivity of thiol groups in proteins, their intracellular signaling events have not yet been clearly documented. This study demonstrated the methane sulfonate chemical 1,4-butanediyl-bismethanethiosulfonate (BMTS)-induced cascades of signals that ultimately led to apoptosis of Jurkat cells. BMTS induced apoptosis through fragmentation of DNA, activation of caspase-9 and caspase-3, and downregulation of Bcl-2 protein with reduction of mitochondrial membrane potential. Moreover, BMTS intensely and transiently induced intracellular reactive oxygen species (ROS) production and ROS produced by BMTS was mediated through mitochondria. We also found that a reducing agent dithiothreitol (DTT) and an anti-oxidant N-acetyl cysteine (NAC) inhibited BMTS-mediated caspase-9 and -3 activation, ROS production and induction of Annexin V/propidium iodide double positive cells, suggesting the involvement of ROS in the apoptosis process. Therefore, this study further extends our understanding on the basic mechanism of redox-linked apoptosis induced by sulfhydryl-reactive chemicals.


Subject(s)
Apoptosis/drug effects , Mitochondria/drug effects , Reactive Oxygen Species/metabolism , Thiosulfonic Acids/pharmacology , Acetylcysteine/pharmacology , Apoptosis/physiology , Caspase 3/metabolism , Caspase 9/metabolism , DNA Fragmentation/drug effects , Dithiothreitol/pharmacology , Free Radical Scavengers/pharmacology , Humans , Jurkat Cells , Membrane Potential, Mitochondrial/drug effects , Membrane Potential, Mitochondrial/physiology , Mitochondria/metabolism , Oxidation-Reduction , Proto-Oncogene Proteins c-bcl-2/metabolism , Signal Transduction/drug effects , Signal Transduction/physiology
4.
Apoptosis ; 13(4): 523-30, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18297401

ABSTRACT

Vinorelbine is a chemotherapeutic vinca alkaloid clinically prescribed for non-small cell lung cancer and breast cancer. Here we studied the mechanism for vinorelbine-induced apoptosis in a human T-cell lymphoma. Although vinorelbine induces DNA fragmentation that is inhibited by specific peptide inhibitors for caspases-9 and -3 in Jurkat cells, caspase-8 deficiency retards vinorelbine-induced apoptosis. Activation of caspase-8 is also observed in vinorelbine-treated cells, and the activity is diminished when the caspase-3 activity is blocked by a specific peptide inhibitor, Ac-DNLC-CHO. Blocking of the Fas receptor with an antagonistic anti-Fas antibody does not affect vinorelbine-induced DNA fragmentation. These results suggest that vinorelbine-induced apoptosis is enhanced by the activation of caspase-8 via caspase-9-mediated activation of caspase-3, but not through a Fas-triggered signal. Western blotting suggests that vinorelbine cleaves caspase-3, -9 and -8 and reduces the amount of mitochondrial cytochrome c. Caspase-8 deficiency suppresses all of these events. A downstream substrate for caspase-8, Bid, is also cleaved in vinorelbine-treated cells, but the Bid truncation is also observed in caspase-8-deficient Jurkat cells. Importantly, recombinant caspases-3 and -9, as well as caspase-8, directly cleaves recombinant Bid in vitro. These results suggest that caspases-3 and -9 participate in Bid truncation, indicating a new mechanism for vinorelbine-induces apoptosis.


Subject(s)
Apoptosis/drug effects , BH3 Interacting Domain Death Agonist Protein/metabolism , Caspase 3/physiology , Caspase 9/physiology , Lymphoma, T-Cell/drug therapy , Vinblastine/analogs & derivatives , Caspase 8/physiology , Cell Line, Tumor , Cytochromes c/metabolism , Humans , Jurkat Cells , Lymphoma, T-Cell/pathology , Vinblastine/pharmacology , Vinblastine/therapeutic use , Vinorelbine
5.
J Invest Dermatol ; 127(5): 1244-9, 2007 May.
Article in English | MEDLINE | ID: mdl-17159911

ABSTRACT

Recently, we crossed an original haired RET-transgenic mouse of line 242 with a hairless mouse and established a hairless RET-(HL/RET)-transgenic mouse line (242-hr/hr) with hyperpigmented skin but no tumors. In this study, we examined the effect of hyperpigmented skin in HL/RET-transgenic mice on UV irradiation-mediated cutaneous cancer development. UV irradiation to this mouse line never induced melanoma despite the presence of melanoma-inducible transgenic RET oncogenes. On the contrary, the hyperpigmented skin efficiently protected UV-mediated squamous carcinoma development in the skin. Probably underlying this result, hyperpigmentation protected the skin from damage and blocked the accompanying signal transduction for tyrosine phosphorylation of multiple cellular proteins and activation/phosphorylation of extracellular signal-regulated, c-Jun N-terminal, and p38 kinases. Thus, we demonstrated hyperpigmentation-mediated in vivo protection against UV irradiation-induced skin cancer.


Subject(s)
Hyperpigmentation/physiopathology , Melanoma/prevention & control , Neoplasms, Radiation-Induced/prevention & control , Skin Neoplasms/prevention & control , Ultraviolet Rays/adverse effects , Animals , Melanins/genetics , Melanins/physiology , Melanoma/genetics , Melanoma/pathology , Mice , Mice, Hairless , Mice, Transgenic , Neoplasms, Radiation-Induced/genetics , Proto-Oncogene Proteins c-ret/genetics , Proto-Oncogene Proteins c-ret/physiology , Signal Transduction/genetics , Signal Transduction/physiology , Skin Neoplasms/genetics , Skin Neoplasms/pathology
7.
FEBS Lett ; 580(3): 839-43, 2006 Feb 06.
Article in English | MEDLINE | ID: mdl-16427628

ABSTRACT

The cysteine in the M/IXXCW motif is conserved in all but one (threonine in place of cysteine) of the human protein tyrosine kinases (PTKs). We showed that all RET-PTC-1 mutants in which the C in this motif (C376) was replaced with glycine, lysine, threonine or serine lost their activity in vitro. However, the C376T/S mutants showed normal tyrosine phosphorylation in vivo (in cells). Further analyses reveled that protein kinase C (PKC) initiated the activities of the C376T/S mutants in cells. We conclude that the M/IXXCW motif-mediated mechanisms which initiate PTK activities are partially replaced by a PKC-mediated mechanism.


Subject(s)
Amino Acid Substitution/genetics , Protein Kinase C/genetics , Protein-Tyrosine Kinases/genetics , Amino Acid Motifs/genetics , Animals , Humans , Mice , NIH 3T3 Cells
8.
Am J Pathol ; 166(3): 831-41, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15743795

ABSTRACT

Interleukin (IL)-6 is a pleiotropic cytokine that has been shown to inhibit the growth of early stage and to promote the proliferation of advanced stage melanoma cells in vitro. In patients with metastasizing melanomas, highly increased IL-6 blood levels correlate with a poor response to chemotherapy and a worse overall prognosis, suggesting that IL-6 promotes melanoma progression in vivo. Here, we analyzed the role of IL-6 in melanoma development and progression in a transgenic mouse model. We bred IL-6-deficient mice with MT-ret transgenic animals predisposed for melanomas. While MT-ret transgenic animals develop severe melanosis of the skin and subcutis and subsequent melanomas at an incidence of 80% during their first year of life, MT-ret mice devoid of IL-6 developed preneoplastic melanosis and consecutive melanomas significantly less frequently (47%; P < 0.05). Moreover, the tumors were significantly smaller in the groups of MT-ret mice lacking one (P < 0.05) or both (P < 0.01) copies of the IL-6 gene. Immunoblot analysis revealed that ret transgene expression was not reduced in the skin of mice lacking IL-6, indicating that the observed decrease of melanoma incidence and of tumor sizes was not because of a down-regulation of transgene expression. Taken together, these results indicate that IL-6 enhances both the development of melanoma precursor lesions and the subsequent growth of the resulting tumors in the MT-ret model of melanoma development.


Subject(s)
Interleukin-6/genetics , Interleukin-6/physiology , Melanoma/genetics , Skin Neoplasms/genetics , Animals , Biopsy , Blotting, Western , Cell Culture Techniques , Cytokines/metabolism , DNA-Binding Proteins/metabolism , Disease Models, Animal , Disease Progression , Down-Regulation , Genotype , Immunoblotting , Immunohistochemistry , Inflammation , Interleukin-6/metabolism , Lectins/metabolism , MAP Kinase Signaling System , Melanoma/metabolism , Melanoma/pathology , Mice , Mice, Transgenic , Necrosis , Phosphatidylinositol 3-Kinases/metabolism , Precancerous Conditions , STAT3 Transcription Factor , Signal Transduction , Skin/pathology , Skin Neoplasms/metabolism , Time Factors , Trans-Activators/metabolism , Transgenes
9.
Arch Biochem Biophys ; 434(1): 3-10, 2005 Feb 01.
Article in English | MEDLINE | ID: mdl-15629102

ABSTRACT

Protein tyrosine kinases (PTKs) play key roles in starting the signal transduction network for cellular development and functions. A number of both receptor-type and non-receptor-type PTKs, which are normally at a resting state, are initially activated in association with functions of the cell membrane and membrane rafts. Results of recent studies have suggested that these membrane-associated mechanisms for activation of PTKs consist of the two steps that are under redox control. The first step is activation of cell surface receptors through chemical crosslinkage or aggregation of receptors and membrane rafts, which leads to production of reactive oxygen species (ROS) as second messengers of intracellular signal transduction. The second step involves chemical modification of PTKs at the highly conserved cysteine in the MXXCW motif as a global switch for starting the tyrosine phosphorylation-dependent local switch for activation of the catalytic activity of the enzyme.


Subject(s)
Cell Membrane/enzymology , Protein-Tyrosine Kinases/metabolism , Amino Acid Sequence , Amino Acids/chemistry , Animals , Catalysis , Humans , Membrane Microdomains/enzymology , Models, Biological , Models, Molecular , Molecular Sequence Data , Oxidation-Reduction , Protein Conformation , Protein-Tyrosine Kinases/chemistry , Protein-Tyrosine Kinases/genetics , Reactive Oxygen Species/metabolism , Second Messenger Systems , Sequence Homology, Amino Acid , Signal Transduction , Tyrosine/chemistry
10.
Nagoya J Med Sci ; 67(3-4): 59-64, 2005 Jun.
Article in English | MEDLINE | ID: mdl-17375471

ABSTRACT

Complete sequencing of the whole genome of humans has revealed a surprisingly small difference between the genomes of humans and higher primates. I here propose that evolution has occurred in living organisms in two steps, first within the genome and then outside the genome. The first step of evolution is based on creation of new information in the genome (DNA), followed by selection after its vertical transmission to individuals of the next generation through reproduction. The second step includes accumulation of a huge amount of information translated into a "linguistic" code by memory and a natural process of computation that creates new patterns of information through thinking in the brain. The created patterns are selected positively or negatively by applying some criteria as to the usefulness for adaptation of humans to nature. When positively selected, the patterns are horizontally transmitted to other brains of a number of individuals, within and also beyond the generation recursively by the use of linguistic codes. This second step of evolution, in conjunction with the evolution of human language itself, has enabled the homo sapiens to attain an enormously high level of cognitive faculty for adaptation of the thought processes to needs in nature at an extraordinarily high speed.


Subject(s)
Biological Evolution , Genome, Human , Humans , Language
11.
Eur J Immunol ; 35(1): 86-97, 2005 Jan.
Article in English | MEDLINE | ID: mdl-15593120

ABSTRACT

Naive T cells do not proliferate but remain alive in vivo. In contrast, naive T cells rapidly die in an in vitro culture, suggesting that some factors that are present at the sites of naive T cell circulation in vivo but missing in the bovine serum-containing culture medium, are necessary for their survival. The present study was designed to search for such factors. By functional screening of the cDNA library from murine lymph node-derived stromal cells (LNS) that effectively support the survival of naive T cells, we found that nascent polypeptide-associated complex (alpha-NAC) promoted T cell survival. A conditioned medium derived from culture supernatant of Cos7 cells transfected with alpha-NAC gene supported T cell survival, indicating that alpha-NAC induced production of soluble factor(s) that were secreted into the medium. By examining the products that were cloned from a functional screening of the cDNA library from alpha-NAC-transfected NIH3T3 cells but were not detected in that from control vector-transfected cells, galectin-1 was found as a soluble factor in the conditioned medium of the LNS. Our study demonstrates the novel role of galectin-1 as a soluble factor that functions to maintain naive T cell survival without inducing cell proliferation.


Subject(s)
Galectin 1/pharmacology , T-Lymphocytes/drug effects , Animals , Apoptosis/drug effects , Base Sequence , COS Cells , Cattle , Cell Proliferation/drug effects , Cell Survival/drug effects , Culture Media, Conditioned , DNA, Complementary/genetics , Galectin 1/genetics , Galectin 1/metabolism , In Vitro Techniques , Lymphocyte Activation , Mice , Molecular Chaperones , NIH 3T3 Cells , Proto-Oncogene Proteins c-bcl-2/metabolism , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Recombinant Proteins/pharmacology , T-Lymphocytes/cytology , T-Lymphocytes/immunology , Trans-Activators/genetics , Trans-Activators/metabolism , Trans-Activators/pharmacology , Transfection , bcl-X Protein
12.
J Exp Med ; 200(9): 1123-34, 2004 Nov 01.
Article in English | MEDLINE | ID: mdl-15520244

ABSTRACT

Regulation of immune system is of paramount importance to prevent immune attacks against self-components. Mice deficient in the interleukin (IL)-2/IL-15 receptor beta chain, CD122, are model animals of such immune attacks and characteristically have a high number of abnormally activated T cells. Here, we show that the transfer of CD8+CD122+ cells into CD122-deficient neonates totally prevented the development of abnormal T cells. Furthermore, recombination activating gene-2-/- mice that received wild-type mice-derived CD8+CD122- cells died within 10 wk after cell transfer, indicating that normal CD8+CD122- cells become dangerously activated T cells in the absence of CD8+CD122+ T cells. CD8+CD122+ cells could control activated CD8+ or CD4+ T cells both in vivo and in vitro. Our results indicate that the CD8+CD122+ population includes naturally occurring CD8+ regulatory T cells that control potentially dangerous T cells.


Subject(s)
CD8-Positive T-Lymphocytes/immunology , Homeostasis/immunology , Receptors, Interleukin-2/immunology , T-Lymphocyte Subsets/immunology , Age Factors , Animals , DNA-Binding Proteins/immunology , Flow Cytometry , Mice , Mice, Mutant Strains , Polymerase Chain Reaction , Receptors, Interleukin-2/genetics , Reverse Transcriptase Polymerase Chain Reaction , T-Lymphocyte Subsets/metabolism
13.
J Cell Biochem ; 93(1): 162-72, 2004 Sep 01.
Article in English | MEDLINE | ID: mdl-15352173

ABSTRACT

Paeoniflorin (PF), isolated from paeony root, has been used as a herbal medicine for more than 1,200 years in China, Korea, and Japan for its anti-allergic, anti-inflammatory, and immunoregulatory effects. In this study, we found that PF induces apoptosis in both murine T-lineage cells and human T-cell leukemia Jurkat cells. This apoptosis was mediated through the reduction of mitochondrial membrane potential, activation of caspase, and fragmentation of DNA. Interestingly, PF induced generation of reactive oxygen species (ROS) and a reducing agent, dithiothreitol (DTT), and a ROS scavenger, N-acetyl cysteine (NAC), successfully attenuated the PF-induced apoptosis. Additionally, PF induced the phosphorylation of three mitogen-activated protein (MAP) family kinases, extracellular signal-regulated kinase, c-Jun amino-terminal kinase (JNK), and p38 MAP kinase. Curcumin, an anti-oxidant and JNK inhibitor, inhibited PF-induced apoptosis, suggesting the possible involvement of curcumin-sensitive JNK or other redox-sensitive elements in PF-induced apoptosis. These results partially explain the action mechanism of PF-containing paeony root as a herbal medicine.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Apoptosis/drug effects , Benzoates/pharmacology , Bridged-Ring Compounds/pharmacology , Glucosides/pharmacology , Lymphocytes/drug effects , Acetylcysteine/pharmacology , Animals , Antioxidants/pharmacology , Caspases/metabolism , Curcumin/pharmacology , Dithiothreitol/pharmacology , Enzyme Activation/drug effects , Enzyme Inhibitors/pharmacology , Humans , Jurkat Cells/drug effects , Jurkat Cells/metabolism , Membrane Potentials/drug effects , Mice , Mitochondria/drug effects , Mitochondria/metabolism , Mitogen-Activated Protein Kinases/antagonists & inhibitors , Mitogen-Activated Protein Kinases/metabolism , Monoterpenes , Oxidation-Reduction , Paeonia/chemistry , Phosphorylation/drug effects , Reactive Oxygen Species/metabolism
14.
Hear Res ; 195(1-2): 35-40, 2004 Sep.
Article in English | MEDLINE | ID: mdl-15350277

ABSTRACT

We report on the cochlea of a novel metallothionein-I (MT)/RFP-RET transgenic mouse model with severe systemic melanosis. Electron microscopy revealed that these transgenic mice possess abundant quantities of melanin in the intermediate cells of the stria vascularis. High performance liquid chromatography analysis indicated that cochleae of these transgenic mice contained about twice as much eumelanin as cochleae of control C57BL/6 mice and that the amount of pheomelanin was approximately equal in these two strains. Auditory brainstem responses at 2, 4, 8, and 16 kHz were not significantly different between transgenic and control mice. This is the first report on a mouse model of overproduction of cochlear eumelanin, and our results suggest that this transgenic mouse is an excellent model for investigating the effects of overexpression of cochlear eumelanin. In addition, we provide evidence that eumelanin overproduction in the cochlea does not affect normal hearing.


Subject(s)
Cochlea/metabolism , Disease Models, Animal , Melanins/metabolism , Melanosis/metabolism , Metallothionein/genetics , Proto-Oncogene Proteins/genetics , Receptor Protein-Tyrosine Kinases/genetics , Animals , Chromatography, High Pressure Liquid , Evoked Potentials, Auditory, Brain Stem , Melanosis/pathology , Melanosis/physiopathology , Mice , Mice, Inbred Strains , Mice, Transgenic , Microscopy, Electron , Proto-Oncogene Proteins c-ret , Severity of Illness Index , Stria Vascularis/metabolism , Stria Vascularis/ultrastructure
15.
Gene ; 336(1): 139-46, 2004 Jul 07.
Article in English | MEDLINE | ID: mdl-15225883

ABSTRACT

The GADD34 gene is transcriptionally induced by growth arrest and DNA damage. However, the mechanisms underlying the transcriptional regulation are still unclear. We analyzed the promoter of mouse GADD34 gene and the methylmethane sulfonate (MMS)-induced transcriptional regulation of this gene. By introducing genome mutants, which were linked to the luciferase reporter, into NIH3T3 cells, we defined a 100-bp fragment upstream of the transcriptional initiating site as the minimal promoter of the GADD34 gene. Subsequent study revealed that CRE-binding site located in this minimal promoter was critical for MMS-induced transcription of the GADD34 gene. In vitro binding experiments showed that phosphorylated c-Jun was contained in the CRE/DNA complex. Overexpression of the dominant negative form of c-Jun led to a decrease of MMS-responsive promoter activity. From these results, we conclude that the CRE site of the GADD34 promoter is indispensable to the MMS-responsive cis-element that c-Jun is the essential transcription factor for MMS-stimulated regulation of GADD34 gene expression and that the upstream signaling is dependent on JNK.


Subject(s)
MAP Kinase Kinase 4 , Methyl Methanesulfonate/toxicity , Mutagens/toxicity , Proteins/genetics , Transcription, Genetic/drug effects , Activating Transcription Factor 2 , Animals , Antigens, Differentiation , Binding Sites/genetics , Cell Cycle Proteins , Cyclic AMP Response Element-Binding Protein/genetics , Cyclic AMP Response Element-Binding Protein/metabolism , Electrophoretic Mobility Shift Assay , Enzyme Activation/drug effects , Gene Expression Regulation/drug effects , Immunoblotting , Luciferases/genetics , Luciferases/metabolism , Mice , Mitogen-Activated Protein Kinase Kinases/metabolism , Mutation , NIH 3T3 Cells , Phosphorylation/drug effects , Promoter Regions, Genetic/genetics , Protein Binding , Protein Phosphatase 1 , Proto-Oncogene Proteins c-jun/genetics , Proto-Oncogene Proteins c-jun/metabolism , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Response Elements/genetics , Transcription Factors/genetics , Transcription Factors/metabolism , Transfection
16.
FEBS Lett ; 567(2-3): 171-4, 2004 Jun 04.
Article in English | MEDLINE | ID: mdl-15178317

ABSTRACT

Okadaic acid (OA) is a protein phosphatase (PP) inhibitor and induces hyperphosphorylation of p53. We investigated whether the inhibition of PP1 by OA promotes the phosphorylation of the serine 15 of p53. In vitro dephosphorylation assay showed that PP1 dephosphorylated ultraviolet C (UVC)-induced phospho-ser15 of p53, and that OA treatment inhibited it. One of the PP1 regulators, growth arrest and DNA damage 34 (GADD34), disturbed PP1 binding with p53, interfered with the dephosphorylation of p53 and increased the amount of phospho-p53 after UVC-treatment. This report provides the first evidence that PP1, but not PP2A, dephosphorylates phospho-serine 15 of p53.


Subject(s)
DNA Damage/physiology , Phosphoprotein Phosphatases/metabolism , Phosphoserine/metabolism , Tumor Suppressor Protein p53/metabolism , Animals , Antigens, Differentiation , Antigens, Polyomavirus Transforming/pharmacology , Cell Cycle Proteins , Cell Line , Cyclin-Dependent Kinase Inhibitor p21 , Cyclins/metabolism , DNA Damage/radiation effects , Embryo, Mammalian/cytology , Enzyme Inhibitors/pharmacology , Eukaryotic Initiation Factor-2/metabolism , Fibroblasts/cytology , Humans , Methyl Methanesulfonate/pharmacology , Mice , Mice, Knockout , Okadaic Acid/pharmacology , Phosphoprotein Phosphatases/antagonists & inhibitors , Phosphorylation , Protein Phosphatase 1 , Protein Phosphatase 2 , Proteins/genetics , Proteins/metabolism , Tumor Suppressor Protein p53/chemistry , Tumor Suppressor Protein p53/genetics , Ultraviolet Rays
17.
Immunology ; 112(1): 64-71, 2004 May.
Article in English | MEDLINE | ID: mdl-15096185

ABSTRACT

We previously developed a transgenic mouse line into which a rabbit protein kinase Calpha (PKCalpha) gene fused to a human CD2 promoter/enhancer was introduced, and we found that immunosenescence was facilitated in these transgenic mice. In this study, we found that along with age-dependent increase in the level of protein expression of PKCalpha and its translocation to the membrane, activated T cells became less sensitive to apoptosis-inducing anti-Fas antibody. The capacity of T cells to express Fas antigen on their surfaces in response to anti-CD3 and interleukin-2 was impaired in PKCalpha-transgenic mice of relatively advanced age, although background Fas expression levels on T cells from those mice were high. We then found that out of proportion to a high level of cell surface Fas expression the density of cholera toxin B (CTx)-binding raft elements decreased in PKCalpha-transgenic mice of relatively advanced age and to a lesser extent in normal mice of advanced age. Correspondingly, the expression level of raft-associating Lck was decreased in these mice. These findings suggest for the first time that immunosenescence of T cells involves a decrease in density of cell surface CTx-binding raft elements, which might underlie a deterioration in T-cell signal pathway for either cell death or cell activation.


Subject(s)
Aging/immunology , Apoptosis/immunology , Membrane Microdomains/immunology , T-Lymphocytes/immunology , fas Receptor/immunology , Animals , Cells, Cultured , Cholera Toxin/metabolism , Disease Models, Animal , Immune Tolerance/immunology , Interleukin-2/immunology , Lymphocyte Activation/immunology , Membrane Microdomains/metabolism , Mice , Mice, Transgenic , Protein Kinase C/genetics , Protein Kinase C/immunology , Protein Kinase C-alpha , Signal Transduction/immunology
18.
Cancer Res ; 64(4): 1496-501, 2004 Feb 15.
Article in English | MEDLINE | ID: mdl-14973052

ABSTRACT

Tumor antigen-reactive T cells can be detected in a large proportion of melanoma patients, but their efficacy on tumor control in vivo remains unclear. On the other hand, vitiligo, a skin disorder characterized by patchy depigmented macules, may occur spontaneously or after antitumor therapies. Moreover, vitiligo is significantly associated with positive clinical response, but the mechanism is not understood. Therefore, the establishment of a relevant animal model in which melanoma and vitiligo spontaneously develop stepwise may be useful for better understanding of the parameters involved in the destruction of both benign and malignant melanocytes. In a previous work, we established a mouse model for melanoma in which MT/ret transgenic mice express the ret oncogene fused to the metallothionein promoter. Here we report that melanoma leads to spontaneous vitiligo. We further investigate, for the first time in this model, the natural antitumor T-cell response and evaluate the role of cellular immunity in the development of the disease. Interestingly, the occurrence of spontaneous tumor nodules in MT/ret mice with melanoma-associated vitiligo is significantly delayed when compared in melanoma mice without vitiligo. Moreover, a significant proportion of mice with melanoma-associated vitiligo resisted a challenge with syngeneic melanoma cells in contrast to animals without vitiligo. Our results confirm that vitiligo is associated with clinical benefit and further demonstrate the crucial role of CD8+ T cells for tumor control in melanoma-associated vitiligo.


Subject(s)
CD8-Positive T-Lymphocytes/immunology , Disease Models, Animal , Melanoma/immunology , Vitiligo/etiology , Animals , Interferon-gamma/biosynthesis , Metals, Heavy/toxicity , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mice, Transgenic , Oncogene Proteins/genetics , Proto-Oncogene Proteins c-ret , Receptor Protein-Tyrosine Kinases/genetics
19.
Mol Pharmacol ; 65(3): 778-87, 2004 Mar.
Article in English | MEDLINE | ID: mdl-14978257

ABSTRACT

Methylglyoxal (MG) is an endogenous metabolite that increases in the blood and tissues of diabetic patients and is believed to be linked to the development of chronic complications of diabetes. We showed previously that Jurkat cells treated with MG rapidly undergo apoptosis via c-Jun N-terminal kinase (JNK) activation. In this study, we examined whether phorbol 12-myristate 13-acetate (PMA) can prevent MG-induced apoptosis in Jurkat cells. The results showed the following: 1) PMA can prevent MG-induced apoptosis; 2) triggering of this antiapoptotic signal depends on the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase (ERK) pathway; 3) PMA inhibits MG-induced activation of caspase-3 and caspase-9, release of cytochrome c, and decline of mitochondrial membrane potential, but it does not affect MG-induced JNK activation; 4) the ERK pathway modulates outer mitochondrial membrane permeability and regulates the mitochondrial death machinery; and 5) activated ERK prevents JNK-induced leakage of cytochrome c from isolated mitochondria. Taken together, these results suggest that PMA-induced ERK activation can protect Jurkat cells from methylglyoxal-induced apoptosis and that activated ERK exerts its antiapoptotic effects on mitochondria by inhibiting activated JNK-induced permeabilization of the outer mitochondrial membrane.


Subject(s)
Apoptosis , Cytochromes c/metabolism , Mitogen-Activated Protein Kinases/metabolism , Pyruvaldehyde/pharmacology , Tetradecanoylphorbol Acetate/pharmacology , Animals , Caspase 8 , Caspases/metabolism , Drug Interactions , Humans , JNK Mitogen-Activated Protein Kinases , Jurkat Cells , MAP Kinase Signaling System/physiology , Mice , Mitochondria/drug effects , Mitochondria/enzymology , Spleen/cytology
20.
Cancer Res ; 64(3): 801-6, 2004 Feb 01.
Article in English | MEDLINE | ID: mdl-14871802

ABSTRACT

The role of c-Kit in the development of melanoma was studied in line 304/B6 of RET-transgenic mice, in which melanoma spontaneously develops. In Wv/Wv-RET (304/B6)-transgenic mice, in which c-Kit function was severely impaired, development of melanoma was strongly suppressed. Although 31 of the 44 original RET-transgenic mice died of rapidly growing melanoma within 12 months after birth, only 8 of the 44 Wv/Wv-RET-transgenic mice developed slowly growing melanocytic tumors with a greatly prolonged mean tumor-free period, 2 of which died of melanoma at a late stage. Even Wv/+-RET-transgenic mice had a clearly prolonged tumor-free period and definitely reduced frequency (6 of 61) of tumor death within 12 months after birth. Melanin production in the skin of these mice was not strongly impaired, suggesting that c-Kit affects the development of melanomas in these mice with only minor effects in melanin production. c-Kit expression in skin soon after birth was promoted in RET-transgenic mice, and c-Kit was expressed at high levels at the benign but not malignant stage of the tumor. A single injection of anti-c-Kit antibody (ACK2) into RET-transgenic mice soon after birth caused a surprisingly long-lasting suppression of development of melanoma, greatly prolonging the tumor-free period, and none of the 28 ACK2-treated RET-transgenic mice died from tumors at 12 months of age. The c-Kit function needed for melanin production was also suppressed for an unusually long time in ACK2-treated, RET-transgenic mice. These results suggest that c-Kit can be a unique target molecule for melanoma treatment.


Subject(s)
Antibodies, Monoclonal/pharmacology , Immunization, Passive/methods , Melanoma, Experimental/immunology , Melanoma, Experimental/prevention & control , Proto-Oncogene Proteins c-kit/immunology , Animals , Antibodies, Monoclonal/immunology , Disease Models, Animal , Drosophila Proteins/genetics , Melanoma, Experimental/genetics , Mice , Mice, Transgenic , Proto-Oncogene Proteins c-kit/biosynthesis , Proto-Oncogene Proteins c-kit/genetics , Proto-Oncogene Proteins c-ret , Receptor Protein-Tyrosine Kinases/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...